Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized H...

por Sun, Sun, Jonsson, Håkan, Salén, Klas-Göran, Andén, Mats, Beckman, Lars, Fransson, Per
Publicado 2022

Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer

por Isaksson, Jenny, Green, Henrik, Papantoniou, Dimitrios, Pettersson, Linn, Anden, Mats, Rosell, Johan, Åvall-Lundqvist, Elisabeth, Elander, Nils Oskar
Publicado 2021